Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
03 02 2021
Historique:
received: 18 12 2020
revised: 22 01 2021
accepted: 28 01 2021
entrez: 6 2 2021
pubmed: 7 2 2021
medline: 18 2 2021
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), comprises mild courses of disease as well as progression to severe disease, characterised by lung and other organ failure. The immune system is considered to play a crucial role for the pathogenesis of COVID-19, although especially the contribution of innate-like T cells remains poorly understood. Here, we analysed the phenotype and function of mucosal-associated invariant T (MAIT) cells, innate-like T cells with potent antimicrobial effector function, in patients with mild and severe COVID-19 by multicolour flow cytometry. Our data indicate that MAIT cells are highly activated in patients with COVID-19, irrespective of the course of disease, and express high levels of proinflammatory cytokines such as IL-17A and TNFα ex vivo. Of note, expression of the activation marker HLA-DR positively correlated with SAPS II score, a measure of disease severity. Upon MAIT cell-specific in vitro stimulation, MAIT cells however failed to upregulate expression of the cytokines IL-17A and TNFα, as well as cytolytic proteins, that is, granzyme B and perforin. Thus, our data point towards an altered cytokine expression profile alongside an impaired antibacterial and antiviral function of MAIT cells in COVID-19 and thereby contribute to the understanding of COVID-19 immunopathogenesis.

Identifiants

pubmed: 33546489
pii: v13020241
doi: 10.3390/v13020241
pmc: PMC7913667
pii:
doi:

Substances chimiques

Cytokines 0
HLA-DR Antigens 0
IL17A protein, human 0
Interleukin-17 0
TNF protein, human 0
Tumor Necrosis Factor-alpha 0
GZMB protein, human EC 3.4.21.-
Granzymes EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 424774790
Organisme : Else Kröner-Fresenius-Stiftung
ID : Else Kröner Memorial Stipend
Organisme : Bavarian State Ministry for Science and the Arts
ID : n.a.

Références

Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Immunity. 2014 May 15;40(5):801-13
pubmed: 24837104
J Exp Med. 2016 Nov 14;213(12):2793-2809
pubmed: 27799620
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
F1000Res. 2020 Jul 9;9:
pubmed: 32695313
Mucosal Immunol. 2020 Sep;13(5):824-835
pubmed: 32112047
Hepatology. 2018 Jul;68(1):172-186
pubmed: 29328499
Nat Commun. 2018 Nov 9;9(1):4706
pubmed: 30413689
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454
pubmed: 33188730
PLoS Pathog. 2015 Aug 21;11(8):e1005072
pubmed: 26295709
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330
Crit Rev Immunol. 2020;40(2):173-184
pubmed: 32749095
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
J Exp Med. 1998 Dec 21;188(12):2205-13
pubmed: 9858507
Autoimmun Rev. 2020 Jul;19(7):102567
pubmed: 32376392
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
PLoS Pathog. 2013;9(10):e1003681
pubmed: 24130485
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Nat Commun. 2018 Aug 22;9(1):3350
pubmed: 30135490
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28
pubmed: 23898209
Ann Transl Med. 2019 Oct;7(19):504
pubmed: 31728357
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Nat Commun. 2016 Jun 23;7:11653
pubmed: 27337592
N Engl J Med. 2009 Dec 24;361(26):2582-3
pubmed: 20032332
Am J Respir Crit Care Med. 2016 Nov 15;194(10):1208-1218
pubmed: 27115408
Nat Rev Microbiol. 2009 Jun;7(6):439-50
pubmed: 19430490
Eur J Immunol. 2014 Jan;44(1):195-203
pubmed: 24019201
Cell Rep. 2019 Sep 17;28(12):3061-3076.e5
pubmed: 31533031
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
PLoS Biol. 2020 Jun 8;18(6):e3000644
pubmed: 32511236
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
Mol Immunol. 2018 Sep;101:155-159
pubmed: 29940408
Eur J Immunol. 2012 Sep;42(9):2221-31
pubmed: 22949320
Blood. 2012 Jan 12;119(2):422-33
pubmed: 22086415
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32886755
J Infect Public Health. 2020 Nov;13(11):1619-1629
pubmed: 32718895
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
Sci Immunol. 2020 Sep 28;5(51):
pubmed: 32989174
Blood. 2011 Jan 27;117(4):1250-9
pubmed: 21084709
Mucosal Immunol. 2015 Mar;8(2):429-40
pubmed: 25269706

Auteurs

Sebastian Deschler (S)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Juliane Kager (J)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Johanna Erber (J)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Lisa Fricke (L)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Plamena Koyumdzhieva (P)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Alexandra Georgieva (A)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Tobias Lahmer (T)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Johannes R Wiessner (JR)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Florian Voit (F)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Jochen Schneider (J)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Julia Horstmann (J)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Roman Iakoubov (R)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Matthias Treiber (M)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Christof Winter (C)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Jürgen Ruland (J)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, 81675 Munich, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Dirk H Busch (DH)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 81675 Munich, Germany.

Percy A Knolle (PA)

Institute of Molecular Immunology and Experimental Oncology, University Hospital Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.

Ulrike Protzer (U)

Institute of Virology, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany.
German Center for Infection Research (DZIF), 38124 Braunschweig, Partner Site Munich, Germany.

Christoph D Spinner (CD)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
German Center for Infection Research (DZIF), 38124 Braunschweig, Partner Site Munich, Germany.

Roland M Schmid (RM)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Michael Quante (M)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Freiburg University Medical Center, Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Katrin Böttcher (K)

Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH